Project Grant K23AR085181
Award Date
5/1/25
Completion Date
4/30/30
Dollars Obligated
$176K
Similar Awards
The U.S. National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) awarded a $163,514 Project Grant under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846) to Brigham & Women's Hospital Inc. in Boston, MA. The grant, awarded on July 1, 2024, supports research to biochemically define a new G protein-coupled receptor (GPCR) signaling pathway with relevance to chemokine signaling and T cell function. The principal investigator, with mentorship...
This $312,627 Project Grant was awarded by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846). The goal of this 4-year project is to establish orbital and cranial vessel wall magnetic resonance imaging (OVW-MRI) as an imaging biomarker for assessing disease activity in giant cell arteritis (GCA), including the risk of ocular involvement. The research will be conducted by The...
This $174,689 Project Grant award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846) will support research conducted by The General Hospital Corporation, doing business as Massachusetts General Hospital, to investigate the relationship between structural damage and pain phenotypes in knee osteoarthritis. The key objectives of the 5-year project are to: 1) examine the link...
This federal Project Grant award under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846), administered by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), provides $1,735,545.00 to The Trustees of the University of Pennsylvania for a study on "Molecular and Clinical Predictors of Relapse in ANCA-Associated Vasculitis". The project aims to advance understanding of disease mechanisms and improve treatment approaches for this...
This $139,895 Project Grant award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846), will support research at Brigham & Women's Hospital Inc. to investigate the role of "trained immunity" in linking inflammatory arthritis and cardiovascular disease development. The research aims to determine whether inflammatory responses in rheumatoid arthritis induce trained...
The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) awarded a $220,224 Project Grant under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846) to The Regents of the University of Colorado (CU) for the project "GRANULAR HYDROGELS FOR THE CONTROLLED DELIVERY OF IMMUNOMODULATORY AND ANGIOGENIC EXTRACELLULAR VESICLES TO ENHANCE BONE TISSUE REGENERATION". The grant, awarded on July 4, 2024, supports CU's research to develop novel...
The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) awarded a $158,912 Project Grant under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846) to The General Hospital Corporation (doing business as Massachusetts General Hospital) to investigate the role of Wnt signaling in the mechanical maturation of tendons. The goal of this 2.5-year research project is to elucidate the functions of Wnt signaling in postnatal tendon maturation and...
The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) awarded a $393,412 Project Grant under CFDA 93.846 (Arthritis, Musculoskeletal and Skin Diseases Research) to Vanderbilt University. The grant, which runs from September 17, 2024 to July 31, 2029, supports research to develop engineered cell therapies as agents for arthritis treatment. Key objectives include characterizing synthetic receptors to drive cartilage repair in an in vitro arthropathy model (Aim 1),...
This federal Project Grant award of $147,400.00 was provided by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846). The grant will fund research at Yale University to investigate how antigen non-related CD4+ T lymphocytes contribute to the pathogenesis of skin fibrosis in systemic sclerosis (scleroderma) and graft-versus-host disease. The research aims to characterize bystander...
This federal Project Grant award, totaling $1,175,680.00, was provided by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846). The aim of this study is to comparatively assess the therapeutic potential of combined anabolic therapy (teriparatide and romosozumab) versus standard single-drug treatment in postmenopausal women at high risk of fragility fracture. The successful...